This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Abbott Laboratories Corporation, Other. Active years: 2006-2010.
Company Filing History:
2 out of 4,186 
1 out of 834,411 Years Active: 2006-2010
Title: The Innovations of Timothy R. Bliese: A Journey Through Patents and Collaborations
Introduction
Timothy R. Bliese, a prominent inventor based in Gurnee, Illinois, has made significant contributions to the field of biotechnology. With three patents to his name, his work primarily focuses on genetically engineered antigens, particularly the P30 antigen. His innovations are poised to enhance the detection of various antibodies, ultimately impacting medical research and diagnostics.
Latest Patents
Timothy R. Bliese’s latest patents showcase his groundbreaking work in the development of genetically engineered antigens. One notable patent describes the "Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof." This invention relates to a genetically engineered P30 antigen combined with other antigens, such as P35. The combination is designed for the detection of IgM and/or IgG antibodies, offering new methods for diagnosing diseases. Additionally, he has patented "Polynucleotide encoding a genetically engineered P30 antigen," which further emphasizes his innovative approach to improving antibody detection through the use of engineered antigens and associated kits and vaccines.
Career Highlights
Throughout his career, Timothy has worked with reputable organizations, including Abbott Laboratories Corporation. His experience in such a dynamic environment has undoubtedly shaped his innovative thinking and problem-solving approaches, allowing him to contribute effectively to advancements in biotechnology.
Collaborations
Timothy R. Bliese has had the opportunity to work alongside talented coworkers, including Gregory Thomas Maine and Chandu B Patel. Collaborations such as these are crucial in the scientific field, as they bring diverse perspectives and expertise that facilitate groundbreaking research and development.
Conclusion
In conclusion, Timothy R. Bliese’s contributions to the realm of biotechnology, particularly in the area of genetically engineered antigens, are noteworthy. His innovative patents hold the potential to revolutionize antibody detection and enhance medical diagnostics. As he continues to collaborate and develop new technologies, the impact of his work will likely be felt across the scientific community and beyond.